Simple HealthKit Expanded Kidney Health Test
Simple HealthKit Launches Expanded Kidney Health Evaluation for Patients with Diabetes (KED) Program to Help Payers Improve Patient Health, Boost STAR Ratings & Meet HEDIS Measures
26 févr. 2024 09h00 HE | Simple HealthKit
Simple HealthKit has launched a new Kidney Health Evaluation for Patients with Diabetes (KED) program to help healthcare payers improve patient health.
Global Chronic Kidney Disease Market Poised for Growth, Projected to Reach $83.6 Billion by 2030
23 janv. 2024 03h08 HE | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to's offering. ...
Use of SGLT2 Inhibit
Use of SGLT2 Inhibitors Continues to Expand for the Treatment of Chronic Kidney Disease, with Eli Lilly/Boehringer Ingelheim’s Jardiance Making Significant Strides Following Label Expansion
03 janv. 2024 16h13 HE | Spherix Global Insights
EXTON, PA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Since 2019, audited records of chronic kidney disease (CKD) non-dialysis patients has revealed an ongoing, annual uptick in the proportion of...
Organ Preservation Solution Market worth $399.49 Billion by 2028 - Exclusive Report by The Insight Partners
08 sept. 2023 06h48 HE | The Insight Partners
Pune, India, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed...
Akebia’s Vafseo (vad
Akebia’s Vafseo (vadadustat) Poised to Make Waves for GSK’s Jesduvroq and FibroGen/Astellas’ Evrenzo
20 juil. 2023 15h07 HE | Spherix Global Insights
Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD) patients....
Straits Research Pvt Ltd
Hemodialysis Market Size is projected to reach USD 136.84 Billion by 2031, growing at a CAGR of 4.8%: Straits Research
06 déc. 2022 10h15 HE | Straits Research
New York, United States, Dec. 06, 2022 (GLOBE NEWSWIRE) -- A hemodialysis is a form of treatment used to remove water and waste from the blood. During kidney failure, dialysis removes wastes such as...
FibroGen to Report Second Quarter 2022 Financial Results
25 juil. 2022 07h00 HE | FibroGen, Inc.
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2022 financial results on Monday, August 8 after the market close. FibroGen will also...
Algernon Logo 1.png
Algernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study
11 juil. 2022 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 11, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian...
Fluorescent Immunoassay Market Size, $3.77Bn by 2028, 5.6% CAGR Led by ELISA Segment (56.12% Market Share in 2021): The Insight Partners
27 mai 2022 06h01 HE | The Insight Partners
NEw York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
$130.37Bn Hemodialysis and Peritoneal Dialysis Market 6.4% CAGR to 2028 Led by Hemodialysis (86.09% Revenue Share in 2022): The Insight Partners
27 mai 2022 02h47 HE | The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis...